Australia's generics sector stresses need for sustainable PBS

14 December 2011

Ensuring the Pharmaceutical Benefits Scheme (PBS) is sustainable and medicines remain affordable and accessible to all Australians regardless of where they live or what their socio economic background is, must be a priority for the new Minister for Health, Tanya Plibersek (The Pharma Letter December 13), said the country’s Generic Medicines Industry Association (GMiA), welcoming Ms Plibersek to her new Cabinet role.

“We congratulate Ms Plibersek and welcome her as our new Minister for Health. Our members are looking forward to a productive and positive working relationship,” chief executive of the GMiA, Kate Lynch said.

Ms Lynch recommends a key focus for the new Minister for Health should be to work with the generic medicines sector to help return significant savings to the economy without cutting into the Pharmaceutical Benefits Scheme (PBS), noting: “Every time a consumer chooses a follow-on generic medicine, there are substantial benefits to national savings.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics